ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 694,64
0,25%
Dow Jones
39 375,87
0,00%
DAX
18 547,14
0,47%
Brent Oil
85,77
-0,85%
Bitcoin
57 200,16
2,42%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BIMI International Medical Inc (BIMI)

  7. BIMI International Medical Inc (BIMI) Actualités

BIMI

BIMI International Medical (BIMI)

BIMI International Medical Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIMI
DateHeureSourceTitreSymboleSociété
20/06/202414h30Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BIMIBIMI International Medical Inc
17/06/202415h44Edgar (US Regulatory)Form SCHEDULE 13D - General statement of acquisition of beneficial ownershipNASDAQ:BIMIBIMI International Medical Inc
13/06/202419h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIMIBIMI International Medical Inc
04/06/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIMIBIMI International Medical Inc
20/05/202422h09GlobeNewswire Inc.BIMI Announces Receipt of a Delinquency Compliance Alert Notice from NasdaqNASDAQ:BIMIBIMI International Medical Inc
11/01/202422h46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BIMIBIMI International Medical Inc
09/01/202422h19Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BIMIBIMI International Medical Inc
03/01/202413h00GlobeNewswire Inc.BIMI Announces Results of 2023 Annual General Meeting of StockholdersNASDAQ:BIMIBIMI International Medical Inc
19/12/202314h01GlobeNewswire Inc.BIMI International Medical Inc. Announces Third Quarter 2023 Financial ResultsNASDAQ:BIMIBIMI International Medical Inc
19/12/202314h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIMIBIMI International Medical Inc
18/12/202312h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BIMIBIMI International Medical Inc
05/12/202322h48Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIMIBIMI International Medical Inc
28/11/202314h00GlobeNewswire Inc.BIMI Announces Buyback of WarrantsNASDAQ:BIMIBIMI International Medical Inc
27/11/202314h25GlobeNewswire Inc.BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)NASDAQ:BIMIBIMI International Medical Inc
27/11/202314h25GlobeNewswire Inc.BIMI International Medical Inc. Announces Second Quarter 2023 Financial ResultsNASDAQ:BIMIBIMI International Medical Inc
15/11/202322h30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BIMIBIMI International Medical Inc
08/11/202315h12GlobeNewswire Inc.BIMI Announces Subsidiary Phenix Bio Inc.’s New Product LaunchNASDAQ:BIMIBIMI International Medical Inc
30/10/202314h29GlobeNewswire Inc.BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of Hong Kong, Taiwan, and Macau Exclusive DistributorNASDAQ:BIMIBIMI International Medical Inc
30/10/202314h27GlobeNewswire Inc.BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of Mainland China Non-Exclusive DistributorNASDAQ:BIMIBIMI International Medical Inc
22/09/202315h00GlobeNewswire Inc.BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of ASEAN Exclusive DistributorNASDAQ:BIMIBIMI International Medical Inc
07/08/202314h00GlobeNewswire Inc.BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free GroupNASDAQ:BIMIBIMI International Medical Inc
16/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIMIBIMI International Medical Inc
22/05/202315h25GlobeNewswire Inc.BIMI International Medical Inc. Announces First Quarter 2023 Financial ResultsNASDAQ:BIMIBIMI International Medical Inc
16/05/202322h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BIMIBIMI International Medical Inc
04/05/202322h07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIMIBIMI International Medical Inc
19/04/202313h32GlobeNewswire Inc.BIMI Announces Results of 2023 Special meeting of Shareholders.NASDAQ:BIMIBIMI International Medical Inc
03/04/202312h17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:BIMIBIMI International Medical Inc
01/03/202314h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIMIBIMI International Medical Inc
13/12/202222h30GlobeNewswire Inc.BIMI Announces Entry into a Material Definitive AgreementNASDAQ:BIMIBIMI International Medical Inc
08/12/202223h00GlobeNewswire Inc.BIMI Announces 1-for -10 Reverse Stock SplitNASDAQ:BIMIBIMI International Medical Inc
 Showing the most relevant articles for your search:NASDAQ:BIMI

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
EU
SGO
Cie de SaintGobain
NYSE
MRK
Merck
EU
HO
Thales
EU
BNP
BNP Paribas
EU
PX4
SBF 120
EU
ACA
Credit Agricole
EU
LR
Legrand
FTSE
UKX
FTSE 100
EU
RNO
Renault
EU
CAP
Capgemini
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
NYSE
NKE
Nike
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés